| Samantha Howard, LPN | |
|
5000 Woodland Dr Apt 68, New Orleans, LA 70131-7606 | |
| (504) 284-1340 | |
| Not Available |
| Full Name | Samantha Howard |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 5000 Woodland Dr Apt 68, New Orleans, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588124788 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | 27209 (Texas) | Secondary |
| 164X00000X | Licensed Vocational Nurse | 347983 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Samantha Howard, LPN 5000 Woodland Dr Apt 68, New Orleans, LA 70131-7606 Ph: (504) 284-1340 | Samantha Howard, LPN 5000 Woodland Dr Apt 68, New Orleans, LA 70131-7606 Ph: (504) 284-1340 |
News Archive
Beckman Coulter announced the results of a prospective study carried out across two European hospitals, which found that Monocyte Distribution Width, in combination with White Blood Cell Count with Differential, has the diagnostic accuracy to detect the risk of sepsis and severe infection upon patient presentation in A&E, particularly when assessed in patients with a lower likelihood of sepsis.
EndoGastric Solutions (EGS), the leader in endoluminal reconstructive treatment for gastroesophageal reflux disease (GERD), announced today that enrollment for the RESPECT study (Randomized EsophyX vs. Sham/Placebo Controlled Trial) is complete and has surpassed the company's original target of 120 patients.
The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.
A study by RCSI indicates that exercise is probably the most effective short-term treatment for depression in people with coronary heart disease, when compared to antidepressants and psychotherapy or more complex care.
Oragenics has announced that the US Patent office has issued a fourth patent (No. 7,067,125), that further describes the composition and uses of the company's exclusively licensed novel antibiotic peptide, MU1140.
› Verified 2 days ago
Michelle Gurley, LPN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 7451 Camberley Dr, New Orleans, LA 70128 Phone: 504-342-8755 |